Main > A1. CORP. INDEX. Bn-Bz > Boehringer Ingelheim/P C2
This data is not available for free
Boehringer Ingelheim/P C2's subsections
2002. 03.15.2002. (Collaboration)
2002. 07.22.2002. (Fine Chemicals)
2002. 09.23.2002. (BioPharma)
2002. 12.02.2002. (Custom Mfg.)
2002. 12.02.2002. (Family Owned)
2002. 12.09.2002. (Custom Mfg.)
2003. 05.12.2003. (Ph Ephrine)
2003. 09.29.2003. (BioPharma)
2004. 08.23.2004. (MorphoSys Deal)
2007. 01.08.2007. (Ablynx)
2007. 07.25.2007. (Pneumo.>COPD)
2007. 08.06.2007. (Princ Scientist)
2007. 08.06.2007. (VP Chem. Dev.)
2007. 09.04.2007. (Cardiology)
2007. 11.20.2007. (BioPharma)
2007. 12.09.2007. (Cardiology)
2008. 02.12.2008. (AIDS)
2008. 02.14.2008. (Oncology)
2008. 09.08.2008. (Board Member)
2008. 09.08.2008. (CN>Supply)
2008. 09.22.2008. Sr Assoc Director
2009. 05.08.2009. Exelixis
2009. 06.08.2009. VP Chem. Dev.
2009. 06.15.2009. Vitae Pharma
2010. 03.30.2010. BI Venture Fund
2010. 09.17.2010. Onco.>Breast C.
2010. 10.26.2010. MacroGenics
2011. 01.11.2011. Eli Lilly
2011. 01.18.2011. Amgen
2011. 02.09.2011. Elan
2011. 10.06.2011. Gilead
2012. 02.21.2012. Xencor
2012. 04.20.2012. Blood Coag.
2012. 05.22.2012. Pneumo.>Asthma
2012. 05.31.2012. Tech Center
2012. 07.23.2012. Funxional Therap.
2012. 07.25.2012. Diab. Lin/Met
2012. 08.03.2012. Servier
2012. 10.02.2012. Diab. Basal
2012. 10.11.2012. Neuro.>Stroke
2013. 03.19. Diab. Lin
2013. 06.06. CN BioPharma.
2013. 06.20. Diab. Lin & Lin/Met
2013. 10.18. Pneumo.>COPD>O
2013. 11.02. Hepato.>HCV>IFN-Free
2013. 12.18. Circuit Therapeutics
2014. 05.15. Onco.>Lung C.
2014. 05.21. Pneumo.>COPD>O+T
2014. 06.20. Hepato.>HCV
2014. 06.30. Blood Coag.
2014. 07.08. Onco.>AML
2014. 08.18. Diab.>Insulin Glargine
2014. 09.18. Onco.>Lung C.>CureVac
2014. 09.25. Pneumo.>COPD>T
2014. 10.29. Diab.>Eli Lilly
2015. 01.15. Sanofi
2015. 01.19. Pneumo.>IPF
2015. 04.13. Hydra Biosciences
2015. 05.18. Hepato.>NASH
2015. 05.26. Pneumo.>COPD>T+O
2015. 05.28. Diab.>E+M
2015. 07.28. Onco.>Lung C.
2015. 08.12. Circuit Therapeutics
2015. 09.21. BioMed X
2015. 11.26. Blood Coag.
2015. 11.30. Diab.>E
2015. 12.15. Bus. Swap Sanofi
2016. 01.13. Arena Pharma.
2017 12.19. Gastro. Roche
2017. 02.15. COPD>Weill Cornell
2017. 03.02. Onco. Vanderbilt Uni.
2017. 09.07. Obesity>Gubra
2017. 11.02. Hepato>NASH>Dicerna
2017. 11.08. Hepato>NASH>MiNA
2018. 04.04. OSE Immunotherapeutics
2018. 09.13. ViraTherapeutics
2019. 03.29. Acq. ICD Therapeutics
2019. 04.09. Stem Cell AH Medicine
2019. 07.01. Hepato.>NASH>Yuhan
2019. 07.15. Onco.>Acq. Amal Therap
2019. 08.12. Onco.>MD Anderson
2019. 09.04. Onco.>Lupin
2019. 09.09. SSc-ILD
2019. 09.20. Inflammasome Therapeut
2019. 10.08. Pneumo.>SSc-ILD
2019. 11.27. Pneumo.>SSc-ILD>CA>OK
2020. 01.06. trival poultry vaccine
2020. 01.27. Diab. 2
2020. 03.09. Pneumo.>ILD
2020. 12.10. Acq. NBE Therapeutics
2022. 09.02. Derma.>GPP>USA>OK
2022. 12.13. EU>EC Approves
2023. 07.25. Nephro>CKD>EU>OK
2023. 11.22. Acq. T3 Pharma. AG
2023. 11.23. AH>Diab. Cats>EU>OK
Boehringer Ingelheim Canada/P C2
Boehringer Ingelheim Chemicals/P C2
Boehringer Ingelheim Corp./P C2
Boehringer Ingelheim Espaņa SA C2
Boehringer Ingelheim Vetmedica/P C2
Patents
Venture Fund. C2
Web-Site
Z - OK
Boehringer Ingelheim/P C2's products
This section has no products